Your browser doesn't support javascript.
loading
A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndrome.
Komrokji, Rami S; Carraway, Hetty E; Germing, Ulrich; Wermke, Martin; Zeidan, Amer M; Fu, Eric; Rüter, Björn; Burkard, Ute; Osswald, Annika; Foran, James M.
Afiliación
  • Komrokji RS; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Rami.Komrokji@moffitt.org.
  • Carraway HE; Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Germing U; Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine University Dusseldorf, Universitätsklinikum, Dusseldorf.
  • Wermke M; NCT/UCC-ECTU, Medical Faculty Carl Gustav Carus, Technical University, Dresden.
  • Zeidan AM; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT.
  • Fu E; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT.
  • Rüter B; Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach/Riss.
  • Burkard U; Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach/Riss.
  • Osswald A; Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach/Riss.
  • Foran JM; Department of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL.
Haematologica ; 107(11): 2742-2747, 2022 11 01.
Article en En | MEDLINE | ID: mdl-35734924

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article